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Abstract: One of the major families of membrane proteins found in prokaryote genome corresponds
to the transporters. Among them, the resistance-nodulation-cell division (RND) transporters are
highly studied, as being responsible for one of the most problematic mechanisms used by bacteria
to resist to antibiotics, i.e., the active efflux of drugs. In Gram-negative bacteria, these proteins are
inserted in the inner membrane and form a tripartite assembly with an outer membrane factor and a
periplasmic linker in order to cross the two membranes to expulse molecules outside of the cell. A lot
of information has been collected to understand the functional mechanism of these pumps, especially
with AcrAB-TolC from Escherichia coli, but one missing piece from all the suggested models is the role
of peptidoglycan in the assembly. Here, by pull-down experiments with purified peptidoglycans, we
precise the MexAB-OprM interaction with the peptidoglycan from Escherichia coli and Pseudomonas
aeruginosa, highlighting a role of the peptidoglycan in stabilizing the MexA-OprM complex and also
differences between the two Gram-negative bacteria peptidoglycans.
Keywords: membrane; peptidoglycan; efflux pump assembly; resistance; Pseudomonas
1. Introduction
The cell wall of Gram-negative bacteria comprises three main layers: the outer mem-
brane lipid bilayer coated by lipopolysaccharides at the exterior; the inner membrane that
meets the cytoplasm; and in between the periplasmic matrix where peptidoglycan (PG)
confers the mechanical rigidity of the cell wall. Membrane transporters such as efflux
pumps span these layers and expulse a wide variety of drugs leading to natural and ac-
quired antimicrobial resistances. Resistance Nodulation-cell Division (RND) family is one
of the six families of efflux pumps [1,2], acting as a three-component complex made of
an inner-membrane transporter (RND), a periplasmic membrane fusion protein (MFP),
and an outer-membrane factor channel (OMF). We focus our interest on the efflux pump
MexAB-OprM from Pseudomonas aeruginosa (P. aeruginosa), an opportunistic Gram-negative
bacterium responsible of severe nosocomial infections and having developed resistance to
several families of antibiotics. It has been recently classified as high priority by WHO in
antimicrobial research [3] and belongs to the group ESKAPE named by the initials of the
pathogens for which there is an urgent need for new treatments. The constitutive RND
efflux pumps MexAB-OprM from P. aeruginosa and AcrAB-TolC from Escherichia coli (E. coli)
have been extensively studied by different approaches making them archetypal models for
the structural and functional comprehension of the efflux pump mechanism. The structure
of each protein forming the pump has been solved by X-ray crystallography [4–12] and the
whole assembly was recently determined by cryo-electron microscopy (cryo-EM) [13–16].
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The comparison of these structures from several homologous pumps, together with in vitro
measurements of transport through proteoliposomes [17,18], in cellulo determination of
the minimal inhibitory concentration (MIC) of antibiotics for mutant strains [19,20], and
the extensive modeling and molecular dynamic calculations [21,22], have led to a more
precise understanding of the efflux pathways [23–28] and the conformational modifica-
tions [14,29,30] necessary to expulse the drugs out of the cell. We know now that the RND
protein works as homotrimer with a proton motive force via proton relay amino acids
localized in the membranous domain. This proton transfer is combined with the movement
of the RND periplasmic domains where each monomer adopts alternatively Loose, Tight,
and Close or Open conformations [31], to capture the drug at different entries and push it
toward the RND funnel domain [16,32]. The drug then crosses the periplasm by a tunnel
formed by the hexameric MFP proteins and is finally expulsed out of the cell through the
OMF channel. Even if some hypotheses have been given on the final opening mechanism
of the OMF [15,33,34], it is still not clear how and when the MFP and OMF interact. In vitro
and in absence of its outer membrane partner, the MFP seems to be unstructured or too
flexible to adopt a defined shape around the RND as illustrated by the recent structure of
TriABC solved by cryo-EM [35]. In cellulo the tripartite pump must traverse the PG layer
to convey the molecules, however, little is known about the relationship between the PG
and the pumps. Is the PG a passive mesh made of long glycan chains crosslinked by short
peptides or does it make specific interactions with the efflux pump components? If yes,
which components are involved in PG recognition? In order to answer these questions, we
purified the PG from E. coli and P. aeruginosa and performed pull-down assays to analyze
their interaction with purified OprM and MexA proteins. Here we show that the presence
of PG stabilizes the MexA-OprM binary complex formation, highlighting the PG as an
important new actor of the assembly of the RND efflux pumps.
2. Results
2.1. Estimation of the Expected PG Interacting Partners
We recently solved the structure of the whole MexAB-OprM pump from P. aeruginosa
by cryo-EM [16] showing a structure of around 230 Å long between the two membranous
domains, which is compatible with the size of the periplasm estimated by cryo-transmission
electron microscopy (Cryo-TEM) [36]. Matias et al. measured frozen-hydrated sections of
E. coli and P. aeruginosa showing some differences between the two bacteria. The distances
between the inner membrane (IM) and the outer membrane (OM) for E. coli and P. aeruginosa
were estimated as 210 Å and 239 Å, respectively, the distances between the PG and the OM
were 53 Å and 61 Å, and the thicknesses of the PG were 63 Å and 24 Å. These measurements
are not necessarily physiological values as the sample preparation with the used technique
resulted in a compression of the bacterial sections that, even if taken into account, increases
the uncertainty on the measure. Nevertheless, the large difference of PG width between
the two bacteria is remarkable. When adding this width difference to the PG-OM distance,
this could reach 116 Å and 85 Å in E. coli and P. aeruginosa, respectively. If we report these
values on the AcrAB-TolC and MexAB-OprM structures (Figure 1), in P. aeruginosa the
PG would surround the ending part of the periplasmic α-helical coiled-coil domain of
OprM and would sweep MexA tips, whereas in E. coli the PG would cover both α-helical
coiled-coil domains of TolC and AcrA. Anyhow, it appeared clearly that the PG do not
interact with the inner membrane RND protein. Consequently, in the present study only
OprM and MexA were analyzed for their possible interaction with PG.
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Figure 1. Schematic representation and localization of the PG. (A) Structures of the efflux pumps AcrAB-TolC 
(left) and MexAB-OprM (right) from E. coli and P. aeruginosa, respectively, presented in their membranous 
environment. Sizes illustrated by blue arrows come from Cryo-TEM measures performed on high-pressure 
freezing bacteria sections [36]. Sizes illustrated by brown arrows have been measured on the 3D structures (PDB 
codes 5ng5 [14] for AcrAB-TolC and 6ta6 [16] for MexAB-OprM). The trimeric OMFs are colored in brown, the 
MFPs' trimers of dimers are colored in green and cyan to highlight the different role of the two MFPs forming the 
dimer, the three monomers forming the RNDs are colored in magenta, yellow and blue depending on their 
respective functioning states (LTO) [4]. Scale is approximate. Lipopolysaccharides (LPS), outer membrane (OM), 
peptidoglycan (PG), inner membrane (IM). (B) General structure of peptidoglycan organization in Gram-negative 
Figure 1. Schematic representation and localization of the PG. (A) Structures of the efflux pumps
AcrAB-TolC (left) and MexAB-OprM (right) fro E. coli and P. aeruginosa, respectively, pres nted in
their membranous environment. Sizes illustrated by blue arrows come from Cryo-TEM measures
performed on high-pressure freezing bacteria sections [36]. Sizes illustrated by brown arrows
have been measured o the 3D structures (PDB c des 5 g5 [14] for AcrAB-TolC an 6ta6 [16] for
MexAB-OprM). The trimeric OMFs are colored in brown, the MFPs’ trimers of dimers are colored
in green and cyan to highlight the different role of the two MFPs forming the dimer, the three
monomers forming the RNDs are colored in magenta, yellow and blue depending on their respective
functioning states (LTO) [4]. Scale is approximate. Lipopolysaccharides (LPS), outer membrane (OM),
peptidoglycan (PG), inner membrane (IM). (B) General structure of peptidoglycan organization in
Gram-negative bacteria: PG is mainly made of repeating units of disaccharide N-acetylglucosamine-
β(1-4)-N-acetylmuramic acid (NAG-NAM) interconnected by tetra- or pentapeptides cross-linked
at amino acid positions 3 and 4 (3-4 crosslinkage). The peptide composition is L-Ala (cyan), D-Ala
(blue), D-Glu (orange) and mDAP (meso-diaminopimelic acid, green). The schematic structures of
the two detergents used to solubilize the membrane proteins OprM and MexA are presented for
comparison: dodecyl-β-D-maltopyranoside (DDM), which has a similar glucidic component to NAG
and NAM, and Octaethylene glycol-monododecyl ether (C12E8).
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2.2. Composition Analysis of the PG from E. coli and P. aeruginosa
The peptidoglycan layer is made of linear chains of two alternating amino sugars:
N-acetylglucosamine (GlcNAc or NAG) and N-acetylmuramic acid (MurNAc or NAM),
which are attached to a short (3- to 5-residue) amino acids chain. The repeating disaccharide-
peptide units are cross-linked via peptide bonds to form a tight mesh barrier (Figure 1B).
Even if it is admitted that the PG of E. coli and P. aeruginosa, both Gram-negative bacteria,
present similar composition [37], we decided to quantify the PG composition of the specific
P. aeruginosa strain used for the binding analysis of this study, PAO1, and to compare it
to the PG of E. coli that has been extensively studied (Table 1). Besides it is necessary to
grow PAO1 in Mueller–Hinton (MH) medium supplemented with salts instead of Luria
or Lysogeny Broth (LB) medium to perform in cellulo anti-bioresistance experiments [38].
Therefore, PAO1 strain was grown in both MH and LB media for comparison. For each
culture, the PG was purified and submitted or not to enzymatic treatments with α-amylase
(E1), to remove high-molecular-weight glycogen, or with both E1 and pronase E (E2), to
remove peptidoglycan associated proteins. Each of the six resulting samples were analyzed
for their respective composition in the characteristic major components of Gram-negative
bacteria, namely NAG, NAM, Ala, Glu, and diaminopimelic acid (DAP) (Figure 1B). The
content of Gly is analyzed to verify the absence of protein contaminants although it occurs
that a few amount of Gly can be found at position 4 or 5 of the peptide instead of the
D-Ala [39]. We show that the treatment with the proteases is necessary to eliminate
residual proteins or peptides co-purified with the PG. Nevertheless, in our study the
first enzymatic treatment with α-amylase seems to be sufficient for the PG purification.
No significant difference was observed between the cultures performed in LB or in MH
medium. The relative ratio of NAG/NAM/Ala/Glu/DAP is close to 1/1/1.5/1/1 as
expected for P. aeruginosa. The small enrichment in Ala is normal as the peptides linking
the sugars could vary as tri, tetra and pentapeptides depending on the presence of D-Ala
at positions 4 and 5 (Figure 1B) [40,41]. In view of these results, no difference was expected
between pull-down experiments performed with PG purified from PAO1 cultures grown in
LB and treated with α-amylase only or with the two enzymes E1 and E2. As this hypothesis
was verified with our proteins (data not shown), we chose to present only the experiments
performed with the PG treated with the two enzymes for clarity.
Table 1. PG composition of E. coli and P. aeruginosa bacterial strains normalized to the NAG concentration.
NAG NAM Ala Glu DAP Gly
E. coli
crude PG extract 1 0.93 6.35 5.81 0.98 3.19
purified PG 1 0.98 1.82 1.13 1.03 0.19
P. aeruginosa
LB medium
crude PG extract 1 1.02 2.38 1.78 1.11 0.31
LB medium
PG treated by E1 1 0.98 1.57 1.06 0.99 0.04
LB medium
PG treated by E1+E2 1 0.98 1.60 1.16 1.00 0.08
MH medium
crude PG extract 1 0.94 2.70 2.21 1.11 0.63
MH medium
PG treated by E1 1 1.03 1.58 1.09 1.02 0.03
MH medium
PG treated by E1+E2 1 0.98 1.60 1.25 1.05 0.19
Int. J. Mol. Sci. 2021, 22, 5328 5 of 12
2.3. Pull-Down Analysis of MexA and OprM with Purified PG
2.3.1. Comparison of the PG from E. coli and P. aeruginosa
To analyze the possible interaction between the upper part of the MexAB-OprM
efflux pump and the PG, pull-down experiments were performed. The MexA and OprM
proteins have been purified from recombinant expression in E. coli C43 strain driving our
choice to first analyze their interaction with the PG of E. coli. The PG has been purified
classically [39] from a culture performed on an untransformed C43 strain stopped during
the exponential phase of growth. After PG incubation with MexA, OprM, or the complex
MexA-OprM at a 2:1 ratio, each sample was extensively washed and the pull-down pellet
of PG analyzed by SDS-PAGE, as well as the supernatant of each washing step of the
pull-down experiment. As shown in Figure 2, although the PG does not retain most of the
proteins, there is still a small proportion of MexA present in the PG pellet, which is not the
case for OprM. Concerning the MexA-OprM complex, it clearly appears a supplementary
band of OprM, suggesting the complex MexA-OprM-PG affinity to be strong enough to
resist to the extensive washing procedure after incubation with the PG, or a stabilization of
the MexA-OprM complex in presence of the PG.
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The same experiment was performed with the PG purified from PAO1 in exactly the
same conditions. No interaction can be observed between OprM and the PG nor between
MexA and PG. Nevertheless, when a pre-mixing of the proteins was performed before
the pull-down assay, the complex was retained by the PG of P. aeruginosa as observed
previously with the PG of E. coli. For both experiments, the specificity of the pull-down has
been verified by releasing MexA and OprM after PG hydrolysis with lysozyme (Figure 2).
2.3.2. Effects of Different Parameters on the Co-Precipitation of MexA-OprM with PG from
P. aeruginosa
In order to verify the specificity of the stabilized complex, several controls were
performed. As MexA and OprM are proteins from P. aeruginosa, these experiments were
only performed with the PG extracted from this bacterium.
To verify that the presence of PG did not modify the MexA:OprM complex ratio,
the experiment was repeated with a 3:1 ratio. The excess of MexA did not modify the
relative intensity of the bands in the retained complex (Figure S1), even if more complexes
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were trapped, indicating that only the 2:1 ratio was stabilized by the PG if referring to our
previous intensities calibration [42].
The C-terminus of OprM, corresponding to the 13 last amino acids, was not visible in
any structure of OprM resolved by crystallography or cryo-EM. As no functional role of
this fragment has been identified so far, it has been hypothesized it could play a role in the
PG recognition. The pull-down experiment was repeated with this OprM∆Cter protein.
No significant difference was detectable in the quantity of MexA-OprM∆Cter complex
retained by PG compared to the MexA-OprM complex analyzed in the same conditions
(see Figure S2).
Another parameter that can modify the result is the nature of the detergent. The
chosen detergent, DDM, is the one that has been used to purify and to solve the structure
of the isolated proteins and that of the whole pump reconstituted in nanodiscs [11,12,16].
Nevertheless, as the maltoside head group of this detergent can mimic the NAG-NAM
disaccharide structure of the PG (Figure 1B), it can be conceived that the presence of the
detergent can perturb the interaction of the proteins with the PG. Consequently, a change of
detergent was performed for OprM and MexA, replacing DDM by C12E8, a PEG alkyl ether
detergent presenting no similarity with the PG structure (Figure 1B). The co-precipitation
with PG was performed in the same conditions as used for the proteins in DDM. As
shown on Figure 3, a faint interaction of OprM(C12E8) and of MexA(C12E8) with PG is
now observed. However, unexpectedly, when the proteins are purified in this detergent
the quantity of the retained complex is largely increased, confirming a stabilization of the
complex by PG but also revealing an effect of the detergent on this interaction. From the
final evaluation of the relative intensity of the bands corresponding to the retained proteins,
even though a large quantity of MexA is released after the first washing step (Figure 3), the
MexA:OprM pull-down ratio in C12E8 seems to be comparable to the one observed with
DDM detergent. It is not clear if the detergent is directly involved in the interaction with
the PG, but the behavior of the protein obviously depends on it. For instance, OprM is less
stable in C12E8 as an important quantity of protein was lost during the detergent exchange.
Because the final quantity of retained complex is important, two additional washing steps
were added showing further release of MexA compared to OprM. Thus, instability of the
membrane proteins in this detergent could be a bias in our interpretation of PG pull-down.
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3. Discussion
The RND efflux pumps form a tripartite assembly which go through the two mem-
branes of Gram-negative bacteria and the PG. Even if the distances between these three
elements are known to fluctuate in spite of direct bonding between OM and PG via lipopro-
teins, position of PG has been restricted for long at the equatorial region of the OMF protein
(see [2] for an example). This is mainly due to the fact the first models of the assembly were
built with a direct interaction between the RND transporter and the OMF, suggesting that
the PG could not reach the periplasmic coiled-coil helices of the OMF proteins (TolC or
OprM) already involved in the binding of the MFP (AcrA or MexA). Since 2015, all the
solved cryo-EM structures of AcrAB-TolC [13,14] and MexAB-OprM [15,16] revealed an
elongated pump with a tip-to-tip interaction between the OMF and the MFP changing
our mind about the position and the possible role of PG in the assembly. Nevertheless, as
the PG of E. coli is three times thicker than the one of P. aeruginosa, it is supposed to cover
a large portion of the tripartite assembly, including the coiled-coil domains of TolC and
the α-hairpin loops of AcrA together with part of the equatorial domain of TolC, unlike
the PG of P. aeruginosa that seems to contact the extremities of MexA only (Figure 1A). A
recent structure of AcrAB-TolC solved by cryo-tomography in cellulo [43] confirmed the
suggested interacting domains of the efflux pump with PG.
Concerning their composition, the two purified PGs are very similar as reported
in Table 1. It can be noticed that after the α-amylase action the PG of PAO1 seems to
be already free of residual amino-acids contrarily to the PG of E. coli that is known to
be poorly purified by the sole action of this enzyme. The main difference in crude PG
composition is a clear excess of Glu and Ala, especially with PAO1 grown in MH medium.
This highlights the importance to get rid of residual interacting proteins as they could alter
the binding experiments.
For proteins purified in DDM, when mixed with OprM, no interaction was detected
whatever the PG as shown by the absence of the protein in the pellet after extensive washing
process, even if a faint band was still detected in the supernatant after the second round of
washing, justifying an additional washing step. Concerning MexA, it has been retained
with the PG only when using the E. coli one. This can be due to the thickness difference
between the two PGs. This result indicates a weak interaction that might involve a specific
repartition of polar or basic residues on MexA in favor of PG binding. In the in cellulo
structure of the E. coli efflux pump solved by cryo-tomography, Shi et al. [43] were able
to reconstitute images corresponding only to the bottom part of the pump, AcrAB. This
bipartite assembly corresponded to 38% of the reconstituted images and presented AcrA
in a favorable position to be embedded in the PG. On the contrary they did not mention
images corresponding to isolated TolC even if this can also be due to the low resolution
of the method. In order to identify the binding sites with PG on the two proteins, they
did crosslinking with 3,3′-dithiobis(sulfosuccinimidyl propionate) (DTSSP) followed by
mass-spectrometry analysis. They identified several peptides on the two proteins localized
in the equatorial and coiled-coil domains of TolC and in the α-hairpin and lipoyl domains
of AcrA. When comparing the identified peptides with the equivalent ones in OprM and
MexA after sequences alignment, it appears that there is neither conserved residues nor
PG binding-motif. The absence of interaction of OprM with the PGs was not intuitive as
it is postulated that the OMF is positioned in a waiting state until an RND-MFP complex
diffusing in the inner membrane arrives. Nevertheless, it was not excluded that in vitro
the detergent dodecyl-β-D-maltopyranoside (DDM) used for proteins purification could
prevent the proper interaction of PG by competition, as DDM presents sugar moiety similar
to the one in PG unit (see Figure 1B). For comparison, an exchange of detergent to C12E8
was performed for OprM and MexA, revealing a weak interaction of individual proteins
with PG, of the same magnitude as the one observed between MexA (in DDM) and the PG
of E. coli revealing a significant role of the detergent used to purify the proteins.
Concerning the pull-down experiments performed on the pre-mixed MexA-OprM
complex, the two proteins are both retained, suggesting a stabilization of the complex in
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presence of the PG, whatever the PG origin (E. coli or P. aeruginosa, Figure 2). Despite the
lack of structural information, it was very tempting to consider the last 13 C-terminus
residues of OprM to interact with the PG as this part of the protein is rich in polar (Thr, Gln)
and charged (Lys) amino acids able to interact with the NAG-NAM or the DAP as observed
by Boags et al. [44] in a molecular dynamic study on the interaction of TolR and OmpA
with PG. Their calculation resulted in the prediction of a predominant role of the flexible
C-terminus of TolR involved in first anchoring of the protein to the PG before making more
specific interaction. To explore this hypothesis, the pull-down experiment was repeated
with the OprM protein deleted of its 13 last amino acids, not visible in the crystallographic
nor the cryo-EM structures, but the use of this truncated OprM∆Cter did not modify the
result of the pull-down experiment, the quantity of MexA-OprM∆Cter complex stabilized
by PG being conserved (see Figure S2), thus invalidating a role of OprM C-terminus in the
stabilization by PG. Concerning the experiments performed with the MexA-OprM complex
after an exchange of detergent, the stabilization of the complex seems largely increased,
even if a large amount of MexA is present in the supernatant after the first washing step
(Figure 3). This stabilization can be due to the nature and the length of the C12E8 detergent
which is longer than DDM. Nevertheless, a synergistic interaction is also observed when
using C12E8 detergent and the PG seems to rebalance the quantity of protein forming
the complex.
This synergistic interaction with PG was previously suggested by Xu et al. [45] when
studying the binding of TolC and AcrA with the PG of E. coli. Nevertheless, the results
were not easy to compare as only the final PG pellet after mixing with TolC and AcrA was
analyzed on an SDS-PAGE revealed by Western blot. This stabilization can be interpreted
by two different hypotheses. It can be due to specific electrostatic interactions as the helical
domains of the two proteins are submitted to large conformation changes during the
assembly and opening process that could make particular regions accessible during the
process. Nevertheless, it is difficult to know at which step the proteins will be in position
to interact with the PG, preventing from a rigorous model building. The second hypothesis
could be a geometrical restriction. The structure of a synthetic PG has been solved by
NMR [46] and the structure of TolC was docked in the PG holes showing that the protein
can enter in the PG without enlargement of the holes by enzymes as the PG pores diameter
have been measured to be ≈70 Å. Nevertheless, at that time the PG interacting zone was
suggested to be the equatorial domain of TolC measured to be as large as the PG hole. The
coiled-coil domain diameter is smaller favoring the insertion of the protein. On the MFP
side, the helical tips of the hexamer form a circle larger than the TolC or OprM extremity
but still slightly smaller than 70 Å, with an enlargement when in complex with the OMF
proteins. So, it can be suggested that MexA do not interact with the PG when uncomplexed
as its hexameric tunnel is too small. In presence of OprM, the slightly enlarged tunnel of
MexA would be sufficient to contact the PG, stabilizing the complex. It will be difficult
to decide between the two hypotheses, but in both cases the PG clearly appears as an
important player in the mechanism of the pump assembly.
4. Materials and Methods
4.1. Purification of the Peptidoglycan
PGs from E. coli and P. aeruginosa were prepared according to the methods of Mengin-
Lecreulx and van Heijenoort [47] with some modifications. Cultures of E. coli were per-
formed in LB and cultures of P. aeruginosa were performed in LB or in MH media. They
were grown at 37 ◦C under 180 rpm agitation until reaching the middle of the exponential
phase at an optical density OD600nm of 0.8. It is important to stop all the cultures at the
same growing step, here the exponential phase, as the composition of PG is growth-phase
dependent [47–49]. A similar protocol was used to purify the PG from E. coli or P. aerugi-
nosa cultures as follows. Cells are pelleted by centrifugation at 4 ◦C, 5000× g for 30 min
then washed with 25 mL of 0.9% NaCl. Cells are pelleted once again by centrifugation at
4 ◦C, 5000× g for 30 min and resuspended in 10 mL of 0.9% NaCl, then added drop by
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drop in 10 mL of boiling SDS 8% with strong stirring. The mixture is left under boiling
conditions for 2 h with stirring then cooled down at room temperature overnight without
stirring and finally centrifuged at 200,000× g, 20 ◦C for 30 min to collect the PG sacculus.
The pellet is washed at least three times to remove SDS with 6 volumes of warm sterile
MilliQ water (30–40 ◦C), centrifuged at 200,000× g, 20 ◦C for 30 min and the final pellet is
resuspended in distilled water or in 10 mM Tris-HCl pH 7.5 if an enzymatic treatment is
performed. The pellet might change from white to transparent during the wash. The final
PG suspension can be used directly or submitted to digestion with proteases in order to
remove the possibly bound proteins. It can be treated with 100 µg/mL α-amylase for 1 h at
37 ◦C then with 200 µg/mL of preheated pronase E overnight at 37 ◦C. The digestions are
stopped by boiling 30 min in 1 volume of SDS at 4% final concentration. The resulting PG,
either collected after the α-amylase digestion or after the second step is then washed as
previously described and the final pellet is resuspended in 1 volume of distilled water for
further use.
For quantification and composition analysis, a small portion (50 µL) of the sample is
hydrolyzed in HCl 6M at 95 ◦C for 16 h, dried, and solubilized in 500 µL of citrate buffer pH
2.2 before analysis with a Hitachi model 8800 amino acid analyzer (ScienceTec) as described
in Barreteau et al. [50]. The characteristic constituents of the PG are N-acetylmuramic acid
(MurNAc or NAM), diaminopimelic acid (DAP) and N-acetylglucosamine (GlcNAc or
NAG) for Gram-negative bacteria, with an expected ratio of approximatively 1:1:1 [47].
4.2. Cloning and Purification of the Analyzed Proteins
Wild type OprM and MexA were cloned and purified following the protocol de-
scribed in [11,42] with minor modifications. OprM deleted of the flexible C-terminus
residues 473–485 (OprM∆Cter) was generated as 5′-NdeI and 3′-XmaI fragment using
polymerase chain reaction (PCR) with PAO1 genome as template. A 6-His tag was in-
cluded at the C-terminus for Ni-NTA affinity purification. Forward and reverse primers are
GGAATTCCATATGAAACGGTCCTTCCTTTCC and TCCCCCCGGGTCATGATGATGAT-
GATGGTCAGGTCTGCTGGTTCCAGCCGCCGCCGA, respectively. The PCR fragment
was then inserted into pBAD33 expression vector as described in [11]. Heterologous ex-
pression of OprM full-length or OprM∆Cter (deletion of the last 13 C-terminus residues
473–485) inserted in a pBAD33 plasmid is performed in a E. coli C43 strain deleted of acrB
gene. The preculture is performed at 37 ◦C in LB medium under 200 rpm agitation and
inoculated at OD600nm = 0.05 in LB medium containing 25 µg/mL of chloramphenicol.
Cell were grown to OD600nm = 0.1 at 37 ◦C, 200 rpm, then cooled down to 20 ◦C. Cells
were induced at OD600nm = 0.7 with arabinose (0.02% final, w/v) and grown overnight
at 20 ◦C before centrifugation. The cell pellet was resuspended in TBS buffer (20 mM
Tris-HCl pH 8, NaCl 150 mM) and broken by the use of a cell disrupter (CellD) at 30,000 psi
(2400 Bar) before centrifugation at 10,000× g for 20 min. The supernatant was diluted
down to 1 mg/mL and solubilized into TBS with DDM 2%, imidazole 10 mM during 1 h at
room temperature. The insoluble fraction is pelleted by ultracentrifugation at 100,000× g
for 1 h at 4 ◦C and the solubilized fraction is loaded on a Ni-NTA column pre-equilibrated
in TBS with 0.05% DDM (w/v). The column is washed with the same buffer supplemented
with 20 mM imidazole pH 8. The protein is eluted between 100 to 250 mM imidazole,
concentrated and injected on a Superdex 200 gel-filtration column equilibrated with the
same buffer without imidazole. OprM is eluted as a trimer and concentrated at 5 mg/mL
before use. MexA is purified following the protocol described in [17] which is similar to
the one used for OprM at the exception of the culture, which is performed in TB medium,
and grown at 30 ◦C during 2.5 h after induction.
The exchange of DDM detergent for C12E8 has been performed on Ni-NTA by reload-
ing the pure proteins on the affinity column. After extensive washing with TBS with
0.025% C12E8 (w/v) and 20 mM imidazole pH 8, the samples were eluted in the same
buffer at 500 mM imidazole. The samples were not further purified but several cycles of
concentration and dilution on amicon®10K were performed to get rid of the imidazole.
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Samples are finally resuspended in TBS with 0.025% C12E8 (w/v) and 300 mM NaCl before
use for the pull-down experiments.
The purify of the proteins can be evaluated by analyzing the well without PG (-PG)
on Figures 2, 3 and S2.
4.3. Pull Down with PG
The purified PG is insoluble in water. It is vortexed before mixing with the proteins.
The pull-down experiment is performed with 50 nmoles of PG (in terms of DAP content,
see paragraph 4.1) in 100 µL of the following buffer: 20 mM Tris-HCl, pH 8.0, 300 mM NaCl,
0.05% DDM. The PG:protein ratio is 100:1 for OprM, 100:2 for MexA, 100:2:1 for MexA-
OprM to account for the 2:1 MexA:OprM ratio in the efflux pump assembly. The mix is
incubated on a rolling wheel for 1 h at room temperature before centrifugation at 18,000× g
for 5 min. The supernatant is kept for further analysis on an SDS-PAGE. The pellet is
washed with 2 volumes of buffer before centrifugation. This washing–centrifugation cycle
is repeated 3 times. The final pellet is resuspended in 1 volume of buffer. The pure protein,
the three supernatants and the final pellet are analyzed on a 12% SDS-PAGE after 5 min
boiling. The experiment was repeated 5 times. For 2 experiments the final pellet was treated
with lysozyme to release the pulled-down proteins. The pellet is resuspended in 1 volume
of buffer with 1 mg/mL final concentration of lysozyme and incubated on a rolling wheel
for 1.5 h at room temperature before centrifugation at 18,000× g for 5 min. The pellet is
washed with 2 volumes of buffer and solubilized in 1 volume. The first supernatant and
the final solubilized pellet after the second washing step are analyzed on a 12% SDS-PAGE.
5. Conclusions
The MexAB-OprM efflux pump spans the complete cell wall of P. aeruginosa, crossing
the peptidoglycan in the periplasmic compartment. Here we analyzed the possible specific
interaction of the MexA and OprM proteins with the PG purified from E. coli or P. aeruginosa
revealing, when proteins are purified in DDM, no interaction for OprM and an interaction
of MexA only with the PG of E. coli that is three times thicker in vivo than the one of
P. aeruginosa. Nevertheless, previous association of the two proteins before analysis reveals
a stabilization of the complex–PG interaction in both cases. This is further reinforced with
the PG of P. aeruginosa after the exchange of DDM detergent for C12E8 for the two proteins.
Even if no covalent binding is expected, this synergistic interaction could correspond
to a required step of the assembly mechanism, suggesting the PG to be an important
actor of the process. It could help to stabilize MexA to keep it in the proper quaternary
structure in order to increase the speed of the pump formation with OprM present in the
opposite membrane.
Supplementary Materials: Supplementary Materials can be found at https://www.mdpi.com/
article/10.3390/ijms22105328/s1. Figure S1: Pull-down experiments performed with the PG extracted
from P. aeruginosa and with the MexA and OprM proteins mixed at two different ratios, 2:1 and 3:1.,
Figure S2: Pull-down experiments performed with the PG extracted from P. aeruginosa and with
the MexA and OprM modified proteins, OprM∆Cter corresponding to a truncation of 13 residues
at its C-terminus.
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